Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sarcoidosis | 6 | 2019 | 271 | 2.01 | Why? |
| Mucin-1 | 7 | 2021 | 277 | 2.00 | Why? |
| Idiopathic Pulmonary Fibrosis | 5 | 2019 | 595 | 1.48 | Why? |
| Pleural Diseases | 2 | 2019 | 68 | 1.41 | Why? |
| Hexosaminidases | 2 | 2019 | 6 | 0.98 | Why? |
| Asthma, Aspirin-Induced | 1 | 2019 | 15 | 0.81 | Why? |
| Muramidase | 1 | 2019 | 24 | 0.78 | Why? |
| Yellow Nail Syndrome | 1 | 2018 | 5 | 0.74 | Why? |
| Granuloma | 2 | 2019 | 88 | 0.74 | Why? |
| Lung Diseases, Interstitial | 2 | 2019 | 1476 | 0.71 | Why? |
| Leukemia, Myelomonocytic, Chronic | 1 | 2017 | 37 | 0.70 | Why? |
| Alveolitis, Extrinsic Allergic | 1 | 2017 | 37 | 0.69 | Why? |
| Omalizumab | 1 | 2019 | 158 | 0.67 | Why? |
| Nasal Polyps | 1 | 2019 | 221 | 0.63 | Why? |
| Scleroderma, Systemic | 2 | 2019 | 583 | 0.59 | Why? |
| Cigarette Smoking | 1 | 2019 | 337 | 0.58 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.56 | Why? |
| Anti-Asthmatic Agents | 1 | 2019 | 427 | 0.54 | Why? |
| Trace Elements | 1 | 2017 | 284 | 0.51 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2019 | 2309 | 0.50 | Why? |
| Body Fluids | 1 | 2017 | 451 | 0.49 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.48 | Why? |
| Indoles | 2 | 2019 | 1243 | 0.47 | Why? |
| Proteins | 1 | 2019 | 921 | 0.45 | Why? |
| Lung | 9 | 2020 | 31049 | 0.41 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.38 | Why? |
| Biomarkers | 10 | 2021 | 23361 | 0.36 | Why? |
| Lung Diseases | 3 | 2019 | 2361 | 0.32 | Why? |
| Prognosis | 9 | 2021 | 32490 | 0.29 | Why? |
| Cough | 1 | 2018 | 4891 | 0.27 | Why? |
| Dyspnea | 1 | 2017 | 3847 | 0.27 | Why? |
| Steroids | 2 | 2021 | 904 | 0.26 | Why? |
| Lymphocyte Subsets | 2 | 2020 | 987 | 0.25 | Why? |
| Microscopic Polyangiitis | 1 | 2021 | 31 | 0.23 | Why? |
| Immunization, Passive | 1 | 2018 | 10067 | 0.22 | Why? |
| Heart-Lung Transplantation | 1 | 2020 | 39 | 0.22 | Why? |
| Vital Capacity | 2 | 2019 | 399 | 0.21 | Why? |
| Maximal Midexpiratory Flow Rate | 1 | 2019 | 15 | 0.21 | Why? |
| Birt-Hogg-Dube Syndrome | 1 | 2019 | 6 | 0.20 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.20 | Why? |
| Respiratory Insufficiency | 2 | 2020 | 7301 | 0.20 | Why? |
| S100 Calcium Binding Protein A6 | 1 | 2019 | 2 | 0.20 | Why? |
| Therapeutics | 1 | 2019 | 35 | 0.20 | Why? |
| Proteomics | 3 | 2019 | 2481 | 0.20 | Why? |
| Forced Expiratory Volume | 2 | 2019 | 632 | 0.19 | Why? |
| Pulmonary Fibrosis | 2 | 2019 | 1068 | 0.19 | Why? |
| 14-3-3 Proteins | 1 | 2019 | 55 | 0.18 | Why? |
| Respiratory Hypersensitivity | 1 | 2019 | 103 | 0.18 | Why? |
| Whole Exome Sequencing | 1 | 2020 | 437 | 0.18 | Why? |
| Tumor Suppressor Proteins | 1 | 2019 | 165 | 0.18 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.17 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2019 | 9659 | 0.17 | Why? |
| Hydroxyurea | 1 | 2017 | 87 | 0.17 | Why? |
| Medical History Taking | 1 | 2019 | 350 | 0.17 | Why? |
| Proto-Oncogene Proteins | 1 | 2019 | 340 | 0.16 | Why? |
| Cell Cycle Proteins | 1 | 2019 | 297 | 0.16 | Why? |
| Sarcoidosis, Pulmonary | 1 | 2017 | 91 | 0.16 | Why? |
| Oxidative Stress | 2 | 2017 | 2050 | 0.15 | Why? |
| Bronchiolitis | 1 | 2020 | 297 | 0.15 | Why? |
| Serum Amyloid A Protein | 1 | 2017 | 211 | 0.15 | Why? |
| Pericardial Effusion | 1 | 2020 | 312 | 0.15 | Why? |
| Rheumatologists | 1 | 2019 | 346 | 0.15 | Why? |
| Antirheumatic Agents | 2 | 2020 | 3023 | 0.14 | Why? |
| Bronchoalveolar Lavage | 1 | 2019 | 603 | 0.14 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.14 | Why? |
| Disease-Free Survival | 1 | 2019 | 1654 | 0.14 | Why? |
| Autoimmunity | 1 | 2021 | 841 | 0.13 | Why? |
| Smokers | 1 | 2019 | 550 | 0.13 | Why? |
| Humans | 35 | 2021 | 930598 | 0.13 | Why? |
| Exhalation | 1 | 2017 | 441 | 0.13 | Why? |
| Killer Cells, Natural | 2 | 2020 | 2093 | 0.13 | Why? |
| Patient Preference | 1 | 2020 | 750 | 0.13 | Why? |
| Drug Hypersensitivity | 1 | 2019 | 401 | 0.13 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.12 | Why? |
| ROC Curve | 2 | 2020 | 6024 | 0.11 | Why? |
| Male | 21 | 2021 | 367725 | 0.11 | Why? |
| Dyslipidemias | 1 | 2017 | 791 | 0.11 | Why? |
| Pneumothorax | 1 | 2019 | 758 | 0.10 | Why? |
| Hand Disinfection | 1 | 2020 | 1671 | 0.10 | Why? |
| Aged | 15 | 2021 | 215776 | 0.10 | Why? |
| Toll-Like Receptor 7 | 1 | 2013 | 402 | 0.10 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.10 | Why? |
| Tomography, X-Ray Computed | 5 | 2020 | 25144 | 0.09 | Why? |
| Female | 18 | 2021 | 380317 | 0.09 | Why? |
| Oxygen | 2 | 2020 | 3715 | 0.09 | Why? |
| Arthritis, Rheumatoid | 1 | 2020 | 2043 | 0.08 | Why? |
| Risk Factors | 3 | 2019 | 71621 | 0.07 | Why? |
| Ultrasonography | 1 | 2020 | 4409 | 0.07 | Why? |
| Rheumatic Diseases | 1 | 2020 | 2675 | 0.07 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.06 | Why? |
| C-Peptide | 1 | 2021 | 77 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Gloves, Surgical | 1 | 2020 | 50 | 0.05 | Why? |
| Asthma | 1 | 2019 | 4383 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.05 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2013 | 3607 | 0.05 | Why? |
| Kidney Diseases, Cystic | 1 | 2019 | 30 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Ceftriaxone | 1 | 2020 | 365 | 0.04 | Why? |
| Cysts | 1 | 2019 | 94 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Antigens | 1 | 2019 | 267 | 0.04 | Why? |
| Methotrexate | 1 | 2021 | 471 | 0.04 | Why? |
| Analysis of Variance | 1 | 2020 | 950 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Joint Diseases | 1 | 2018 | 122 | 0.04 | Why? |
| Genetic Testing | 1 | 2019 | 395 | 0.04 | Why? |
| Retrospective Studies | 4 | 2020 | 105322 | 0.04 | Why? |
| Bronchodilator Agents | 1 | 2020 | 444 | 0.03 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.03 | Why? |
| Th17 Cells | 1 | 2019 | 657 | 0.03 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.03 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.03 | Why? |
| Eye | 1 | 2018 | 374 | 0.03 | Why? |
| Tertiary Healthcare | 1 | 2018 | 616 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2019 | 88759 | 0.03 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2019 | 698 | 0.03 | Why? |
| Interleukin-6 | 2 | 2021 | 7522 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Recurrence | 1 | 2021 | 3675 | 0.03 | Why? |
| Interviews as Topic | 1 | 2020 | 1952 | 0.03 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.03 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Italy | 3 | 2021 | 38444 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.02 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Obesity, Morbid | 1 | 2020 | 1340 | 0.02 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Eye Diseases | 1 | 2018 | 1150 | 0.02 | Why? |
| Skin | 1 | 2018 | 2096 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Skin Diseases | 1 | 2018 | 2509 | 0.01 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2013 | 4027 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
Bargagli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(91)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_